159 related articles for article (PubMed ID: 18398023)
1. Recruitment in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: the first phase of recruitment at Henry Ford Health System.
Lamerato LE; Marcus PM; Jacobsen G; Johnson CC
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):827-33. PubMed ID: 18398023
[TBL] [Abstract][Full Text] [Related]
2. Recruitment strategies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: the first six years.
Simpson NK; Johnson CC; Ogden SL; Gamito E; Trocky N; McGuire C; Martin J; Barrow S; Lamerato L; Flickinger LM; Broski KG; Engelhard D; Hilke C; Bonk J; Gahagan B; Gren LH; Childs J; Lappe K; Fouad M; Thompson J; Sullivan D;
Control Clin Trials; 2000 Dec; 21(6 Suppl):356S-378S. PubMed ID: 11189688
[TBL] [Abstract][Full Text] [Related]
3. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status.
Gohagan JK; Prorok PC; Hayes RB; Kramer BS;
Control Clin Trials; 2000 Dec; 21(6 Suppl):251S-272S. PubMed ID: 11189683
[TBL] [Abstract][Full Text] [Related]
4. Validation of Self-Report of Chest X-Ray Exam at a Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Center.
Gren LH; Lamerato LE; Wright P; Marcus PM
Rev Recent Clin Trials; 2015; 10(3):194-9. PubMed ID: 26238206
[TBL] [Abstract][Full Text] [Related]
5. Black participation in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
Stallings FL; Ford ME; Simpson NK; Fouad M; Jernigan JC; Trauth JM; Miller DS;
Control Clin Trials; 2000 Dec; 21(6 Suppl):379S-389S. PubMed ID: 11189689
[TBL] [Abstract][Full Text] [Related]
6. Managing Multi-Center Recruitment in the PLCO Cancer Screening Trial.
Gohagan JK; Broski K; Gren LH; Fouad MN; Higgins D; Lappe K; Ogden S; Shambaugh V; Pinsky PF; O'Brien B; Yurgalevich S; Riley T; Wright P; Prorok PC
Rev Recent Clin Trials; 2015; 10(3):187-93. PubMed ID: 26435288
[TBL] [Abstract][Full Text] [Related]
7. Recruitment methods employed in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Gren L; Broski K; Childs J; Cordes J; Engelhard D; Gahagan B; Gamito E; Gardner V; Geisser M; Higgins D; Jenkins V; Lamerato L; Lappe K; Lowery H; McGuire C; Miedzinski M; Ogden S; Tenorio S; Watt G; Wohlers B; Marcus P
Clin Trials; 2009 Feb; 6(1):52-9. PubMed ID: 19254935
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting older african american women's decisions to join the PLCO Cancer Screening Trial.
Trauth JM; Jernigan JC; Siminoff LA; Musa D; Neal-Ferguson D; Weissfeld J
J Clin Oncol; 2005 Dec; 23(34):8730-8. PubMed ID: 16314633
[TBL] [Abstract][Full Text] [Related]
9. Enrollment of racial and ethnic minorities in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
Pinsky PF; Ford M; Gamito E; Higgins D; Jenkins V; Lamerato L; Tenorio S; Marcus PM; Gohagan JK
J Natl Med Assoc; 2008 Mar; 100(3):291-8. PubMed ID: 18390022
[TBL] [Abstract][Full Text] [Related]
10. Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
Miller AB; Yurgalevitch S; Weissfeld JL;
Control Clin Trials; 2000 Dec; 21(6 Suppl):400S-406S. PubMed ID: 11189691
[TBL] [Abstract][Full Text] [Related]
11. Quality control of cancer screening examination procedures in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
Weissfeld JL; Fagerstrom RM; O'Brien B;
Control Clin Trials; 2000 Dec; 21(6 Suppl):390S-399S. PubMed ID: 11189690
[TBL] [Abstract][Full Text] [Related]
12. Update of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Andriole GL
Recent Results Cancer Res; 2014; 202():53-7. PubMed ID: 24531777
[TBL] [Abstract][Full Text] [Related]
13. Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial.
Hayes RB; Reding D; Kopp W; Subar AF; Bhat N; Rothman N; Caporaso N; Ziegler RG; Johnson CC; Weissfeld JL; Hoover RN; Hartge P; Palace C; Gohagan JK;
Control Clin Trials; 2000 Dec; 21(6 Suppl):349S-355S. PubMed ID: 11189687
[TBL] [Abstract][Full Text] [Related]
14. Data Processing and Analytic Support in the PLCO Cancer Screening Trial.
Mabie J; Riley T; Marcus PM; Black A; Rozjabek H; Yu K; Young M; Austin J; Rathmell J; Williams C; Prorok PC
Rev Recent Clin Trials; 2015; 10(3):233-7. PubMed ID: 26238116
[TBL] [Abstract][Full Text] [Related]
15. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
Prorok PC; Andriole GL; Bresalier RS; Buys SS; Chia D; Crawford ED; Fogel R; Gelmann EP; Gilbert F; Hasson MA; Hayes RB; Johnson CC; Mandel JS; Oberman A; O'Brien B; Oken MM; Rafla S; Reding D; Rutt W; Weissfeld JL; Yokochi L; Gohagan JK;
Control Clin Trials; 2000 Dec; 21(6 Suppl):273S-309S. PubMed ID: 11189684
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Quality Management (CQM) in the PLCO Trial.
Gohagan JK; O'Brien B; Hasson MA; Umbel KD; Bridgeman B; Kramer BS; Reding D; Gren L; Wright P; Riley T; Prorok PC
Rev Recent Clin Trials; 2015; 10(3):223-32. PubMed ID: 26238118
[TBL] [Abstract][Full Text] [Related]
17. Coordination and management of a large multicenter screening trial: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
O'Brien B; Nichaman L; Browne JE; Levin DL; Prorok PC; Gohagan JK;
Control Clin Trials; 2000 Dec; 21(6 Suppl):310S-328S. PubMed ID: 11189685
[TBL] [Abstract][Full Text] [Related]
18. Quality of life and trial adherence among participants in the prostate, lung, colorectal, and ovarian cancer screening trial.
Taylor KL; Shelby R; Gelmann E; McGuire C
J Natl Cancer Inst; 2004 Jul; 96(14):1083-94. PubMed ID: 15265970
[TBL] [Abstract][Full Text] [Related]
19. Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination.
Weissfeld JL; Schoen RE; Pinsky PF; Bresalier RS; Doria-Rose VP; Laiyemo AO; Church T; Yokochi LA; Yurgalevitch S; Rathmell J; Andriole GL; Buys S; Crawford ED; Fouad M; Isaacs C; Lamerato L; Reding D; Prorok PC; Berg CD;
J Natl Cancer Inst; 2012 Feb; 104(4):280-9. PubMed ID: 22298838
[TBL] [Abstract][Full Text] [Related]
20. Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
Pinsky PF; Blacka A; Kramer BS; Miller A; Prorok PC; Berg C
Clin Trials; 2010 Aug; 7(4):303-11. PubMed ID: 20571134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
